Oregon Urology

Year	CMS eCQM ID	Measure Name
2023	CMS645v6	Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
2024	CMS645v7	Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
2025	CMS645v8	Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy
2026	CMS645v9	Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy
2023	CMS646v3	Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
2024	CMS646v4	Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
2025	CMS646v5	Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder Cancer
2026	CMS646v6	Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder Cancer

We want your feedback

For technical questions about eCQMs, please log in to the ONC Project Tracking System, specifically the eCQM Issue Tracker.

Summary

eCQI Resource Center Feedback pertains to:

Content

Functionality

Bug

Other

Description

Screenshot

Check the box if you would like a response regarding your feedback.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.